Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NUFORMIX PLC M&A Activity 2022

Dec 20, 2022

4941_rns_2022-12-20_da6930bb-fbfe-4a2b-9d9e-e648c1915e5c.html

M&A Activity

Open in viewer

Opens in your device viewer

News Details

Corporate | 20 December 2022 14:00

Nuformix hoping to ‘initiate discussions with major pharma’ in 2023

EQS-News: Nuformix PLC

Nuformix hoping to 'initiate discussions with major pharma' in 2023

20.12.2022 / 14:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

[email protected]

News Source: News Direct


20.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: Nuformix PLC
United States
ISIN: GB00BYW79Y38
EQS News ID: 1517959
End of News EQS News Service

show this